0001415889-18-001224.txt : 20180806 0001415889-18-001224.hdr.sgml : 20180806 20180806163840 ACCESSION NUMBER: 0001415889-18-001224 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180805 FILED AS OF DATE: 20180806 DATE AS OF CHANGE: 20180806 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DOTSON JERROLD DUANE CENTRAL INDEX KEY: 0001388853 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37761 FILM NUMBER: 18995241 MAIL ADDRESS: STREET 1: 5 CENTERPOINTE DRIVE STREET 2: SUITE 400 CITY: LAKE OSWEGO STATE: OR ZIP: 97035 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VistaGen Therapeutics, Inc. CENTRAL INDEX KEY: 0001411685 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205093315 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 343 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-577-3600 MAIL ADDRESS: STREET 1: 343 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Excaliber Enterprises, Ltd. DATE OF NAME CHANGE: 20070906 4 1 form4-08062018_010826.xml X0306 4 2018-08-05 0001411685 VistaGen Therapeutics, Inc. VTGN 0001388853 DOTSON JERROLD DUANE C/O VISTAGEN THERAPEUTICS, INC. 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 false true false false CFO AND SECRETARY Stock Option (Right to Buy) 1.27 2018-08-05 4 A 0 100000 0 A 2028-08-05 Common Stock 100000 100000 D 25% of the Shares subject to the Option shall vest on Vesting Start Date August 5, 2018, and 1/24th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the Vesting Start Date thereafter. /s/ Jerrold D. Dotson 2018-08-06